NCT05015374View on ClinicalTrials.gov

Effect of Astaxanthin on the Patients With Alzheimer Disease

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 14, 2018

Primary Completion Date

June 1, 2024

Study Completion Date

June 25, 2024

Conditions
To Evaluate the Possible Benefit of Astaxanthin on Alzheimer Disease
Interventions
DIETARY_SUPPLEMENT

Astaxanthin

350 mg/capsule (2mg Astaxanthin)

DIETARY_SUPPLEMENT

Placebo

Placebo

Trial Locations (1)

80756

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

All Listed Sponsors
collaborator

China Medical University, China

OTHER

lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

NCT05015374 - Effect of Astaxanthin on the Patients With Alzheimer Disease | Biotech Hunter | Biotech Hunter